Why Nostr? What is Njump?
2025-04-13 23:06:45
in reply to

feeds.guardian.co.uk on Nostr: feeds.guardian.co.uk ✍️ The NHS in England will provide fast-track access to a ...



✍️ The NHS in England will provide fast-track access to a new cancer vaccine for patients with advanced skin melanoma as part of a trial.
👉 The NHS is launching a trial for a new cancer vaccine, iSCIB1+, for patients with advanced skin melanoma
👉 The vaccine helps the immune system recognize cancer cells and respond to immunotherapy treatment
👉 The trial is part of the Cancer Vaccine Launch Pad (CVLP) program, which aims to provide 10,000 patients in England with personalized cancer treatments by 2030
👉 The trial will be conducted at seven hospitals across the country

#PeterJohnson #KeirStarmer #SusannaDaniels #England #UK #health


NHS Cancer Vaccine Launch Pad expanded to include trial for patients with advanced type of skin cancerPatients with an advanced type of skin melanoma in England will be given fast-track access to a “revolutionary” new cancer vaccine as part of an NHS trial.The vaccine, known as iSCIB1+ (ImmunoBody), helps the immune system recognise cancer cells and therefore better respond to immunotherapy treatment. Continue reading...
https://www.theguardian.com/society/2025/apr/14/melanoma-patients-in-england-get-fast-track-access-to-cancer-vaccine

Author Public Key
npub1veec6wv460ucwnmwa9kdl43d3vhgwnv8cj5eju6tsl95uthn8s9sckhyrj